Cleo Goyvaerts (C Goyvaerts)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Top Venues

EJNMMI research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Guillaume Richer, Cleo Goyvaerts, Lorna Marchandise, Tamara Vanhaecke, Ellen Goossens, Yoni Baert
Spermatogenesis in mouse testicular organoids with testis-specific architecture, improved germ cell survival and testosterone production. Biofabrication 16 (4) (2024)
Thomas Ertveldt, Lien De Beck, Kirsten De Ridder, Hanne Locy, Wout de Mey, Cleo Goyvaerts, Quentin Lecocq, Hannelore Ceuppens, Yannick De De Vlaeminck, Robin Maximilian Awad, Marleen Keyaerts, Nick Devoogdt, Matthias D'Huyvetter, Karine Breckpot, Ahmet Krasniqi
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model. Molecular cancer therapeutics 21 (7) (2022)
Quentin Lecocq, Pieterjan Debie, Janik Puttemans, Robin Maximilian Awad, Lien De Beck, Thomas Ertveldt, Yannick De De Vlaeminck, Cleo Goyvaerts, Geert Raes, Marleen Keyaerts, Karine Breckpot, Nick Devoogdt
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer. EJNMMI research 11 (1) (2021)
Inge Kortekaas Krohn, Joeri L Aerts, Karine Breckpot, Cleo Goyvaerts, Edward F Knol, Femke Van Wijk, Jan Gutermuth
T-cell subsets in the skin and their role in inflammatory skin disorders. Allergy (2021)
Thomas Benoot, Elisa Piccioni, Kirsten De Ridder, Cleo Goyvaerts
TNFα and Immune Checkpoint Inhibition: Friend or Foe for Lung Cancer? International journal of molecular sciences 22 (16) (2021)